Zaynich' US FDA Approval Puts Wockhardt's Innovation Bet To The Test
NDTV.com
June 1, 2026
Zaynich, approved for complicated urinary tract infections and pyelonephritis, is aimed at treating infections caused by drug-resistant bacteria - an area where doctors globally are facing shrinking...
Discussion in the ATmosphere